美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
69452-330-20	69452-330	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20240311	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	1 mg/1	100 CAPSULE in 1 BOTTLE (69452-330-20)
69452-330-32	69452-330	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20241220	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	1 mg/1	1000 CAPSULE in 1 BOTTLE (69452-330-32)
69452-332-20	69452-332	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20240311	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	5 mg/1	100 CAPSULE in 1 BOTTLE (69452-332-20)
69452-332-32	69452-332	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20241220	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	5 mg/1	1000 CAPSULE in 1 BOTTLE (69452-332-32)
69452-333-20	69452-333	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20240311	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	10 mg/1	100 CAPSULE in 1 BOTTLE (69452-333-20)
69452-333-32	69452-333	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20241220	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	10 mg/1	1000 CAPSULE in 1 BOTTLE (69452-333-32)
69452-331-20	69452-331	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20240311	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	2 mg/1	100 CAPSULE in 1 BOTTLE (69452-331-20)
69452-331-32	69452-331	HUMAN PRESCRIPTION DRUG	Terazosin	Terazosin	CAPSULE	ORAL	20241220	N/A	ANDA	ANDA075667	Bionpharma Inc.	TERAZOSIN HYDROCHLORIDE	2 mg/1	1000 CAPSULE in 1 BOTTLE (69452-331-32)